Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T15:35:53.283Z.
Calculation as of: 2026-10-06T15:35:53.283Z.
Quote observation: 2026-10-06T15:30:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dd458a7b7530169a13c79e175a6610edc18df904cb2af71895118b3708428af2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$59.10M
EV/Sales Ratio
N/A
TTM Avg
10156.67x
3Y Avg
5697.35x
5Y Avg
5697.35x
Market Cap
$60.17M
EV/Sales Ratio
N/A
TTM Avg
236.83x
3Y Avg
178.58x
5Y Avg
259.06x
Market Cap
$60.32M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.49M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.87M | N/A | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.34M | N/A | N/A | N/A | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | N/A | 10156.67x | 5697.35x | 5697.35x |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.17M | N/A | 236.83x | 178.58x | 259.06x |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.32M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $60.49M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.08M | 3.78x | 2.57x | 1.84x | 3.18x |
| Adicet Bio, Inc. (ACET)vs › | $61.21M | N/A | 8.16x | 93.50x | 96.95x |
| Aldeyra The (ALDX)vs › | $54.53M | N/A | 3.74x | 3.42x | 3.42x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
